Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 318 followers

Latest posts

Last updated about 9 hours ago

Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec

about 11 hours ago

Pfizer expects 8 blockbuster cancer drugs to come from each of 4...

With phase 3 miss, Pfizer's DMD candidate is no threat to Sarepta's Elevidys ahead of key label expansion: analysts

about 11 hours ago

With phase 3 miss, Pfizer's DMD candidate is no threat to Sarepta's...

ALS market to grow 15% by 2029, boosted by pharmas’ awareness-raising, drug development work: report

about 11 hours ago

ALS market to grow 15% by 2029, boosted by pharmas’ awareness-raising, drug...

European antitrust watchdog accuses API manufacturer Alchem of engaging in price-fixing scheme

about 12 hours ago

European antitrust watchdog accuses API manufacturer Alchem of engaging in price-fixing scheme...

Investment firm Great Point Partners scoops up German CDMO Lyocontract

about 13 hours ago

Investment firm Great Point Partners scoops up German CDMO Lyocontract fkansteiner Thu...

CDMO Siegfried expands U.S. footprint with acquisition of Wisconsin facility

about 14 hours ago

CDMO Siegfried expands U.S. footprint with acquisition of Wisconsin facility jkeenan Thu...

Talc plaintiffs file for restraining order to block Johnson & Johnson's 3rd bankruptcy attempt

about 15 hours ago

Talc plaintiffs file for restraining order to block Johnson & Johnson's 3rd...

Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month on social media

1 day ago

Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month on social media...

WuXi shares jump after BIOSECURE Act's exclusion from defense spending bill

1 day ago

WuXi shares jump after BIOSECURE Act's exclusion from defense spending bill zbecker...

Junshi, Coherus' PD-1 inhibitor Loqtorzi scores in phase 3 liver cancer trial

1 day ago

Junshi, Coherus' PD-1 inhibitor Loqtorzi scores in phase 3 liver cancer trial...

BMS chief Boerner says company is still hungry for deals after spending more than $20B on M&A last year

1 day ago

BMS chief Boerner says company is still hungry for deals after spending...

Amid FTC crackdown, judge says Teva inhaler patents are 'improperly listed' in FDA Orange Book

1 day ago

Amid FTC crackdown, judge says Teva inhaler patents are 'improperly listed' in...